Literature DB >> 2199373

Embryotoxic/teratogenic potential of halothane.

C Baeder1, M Albrecht.   

Abstract

The embryotoxic/teratogenic potential of halothane was evaluated on the basis of available data obtained in an extensive literature search. It was found that halothane induced ultrastructural visible changes in the offspring of rats exposed to concentrations of 10 ppm during gestation. These consisted of degenerative changes in the cerebral cortex and, in particular, the weakening of cell membranes and the vacuolisation of the Golgi-complex. Macroscopically visible morphological changes were seen in rats only after exposure to concentrations equivalent to 320-fold (1600 ppm) the MAK value (maximum concentration value at the workplace). Furthermore, behavioural disorders were seen when exposure to concentrations greater than or equal to 10 ppm occurred during gestation and after parturition. In mice, only macroscopical investigations were performed. The first disturbances scored were only visible as retardation in the offspring, and occurred after exposure to concentrations of halothane 200-fold (1000 ppm) the MAK-value. In the rabbit, anaesthetic concentrations of 22000 ppm halothane did not result in an embryotoxic/teratogenic effect. The individual epidemiological findings in humans were discussed controversially. The studies are inconclusive in establishing an embryotoxic/teratogenic risk following sole exposure to halothane at the MAK level, since mixed exposures occurred and data on the concentrations of halothane in the inhaled air were missing. Therefore, the decision on whether halothane can impair intrauterine development is primarily based on the animal experimental findings. As long as a threshold value has not been established for the observed lesions, halothane should not be inhaled during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199373     DOI: 10.1007/bf00640832

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  42 in total

1.  Lack of teratogenic dangers with halothane.

Authors:  W D Pope; M J Halsey; A B Lansdown; P E Bateman
Journal:  Acta Anaesthesiol Belg       Date:  1975

2.  Effect of halothane on brain 2',3'-cyclic nucleotide 3'-phosphodiesterase during neurodevelopment in the rat.

Authors:  J J Nagelhout; R T Ferdinand; F C Beuthin
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1986-08

3.  [The action of halothane in gausing abortion (author's transl)].

Authors:  R Wittmann; A Doenicke; H Heinrich; H Pausch
Journal:  Anaesthesist       Date:  1974-01       Impact factor: 1.041

4.  [The risks of chronic occupational exposure of pregnant operating theatre personnel to anaesthetic gases (author's transl)].

Authors:  J Stoebbel; G Kalff
Journal:  Z Prakt Anasth Wiederbeleb Intensivther       Date:  1973-10

5.  The teratogenicity of halothane in the rat.

Authors:  A B Basford; B R Fink
Journal:  Anesthesiology       Date:  1968 Nov-Dec       Impact factor: 7.892

6.  [Teratogenic effects of inhalation anesthetics].

Authors:  V Askrog; B Harvald
Journal:  Nord Med       Date:  1970-04-16

7.  [Experimental study on the abortive effects of chlorinated hydrocarbon anaesthetics (author's transl)].

Authors:  G Kessler; G Schöntag
Journal:  Prakt Anaesth       Date:  1978-06

8.  Behavioral consequences in rats from chronic exposure to 10 PPM halothane during early development.

Authors:  K L Quimby; J Katz; R E Bowman
Journal:  Anesth Analg       Date:  1975 Sep-Oct       Impact factor: 5.108

Review 9.  Trace concentrations of anesthetic gases: a critical review of their disease potential.

Authors:  L L Ferstandig
Journal:  Anesth Analg       Date:  1978 May-Jun       Impact factor: 5.108

10.  Fetotoxicity in rats following chronic exposure to halothane, nitrous oxide, or methoxyflurane.

Authors:  W D Pope; M J Halsey; A B Lansdown; A Simmonds; P E Bateman
Journal:  Anesthesiology       Date:  1978-01       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.